Monitoring of clinical events in patients on first line antiretroviral treatment (ART) in poor countries is almost as effective in terms of survival as using CD4 count or viral load measures at ...

Background. It has been suggested that routine CD4 cell count monitoring in human immunodeficiency virus (HIV)–monoinfected patients with suppressed viral loads and CD4 cell counts >300 cell/μL could ...

This table pertains to laboratory tests done to select an ARV regimen and monitor for treatment responses or ART toxicities. Please refer to the HIV Primary Care guidelines for guidance on other ...

A new CD4 testing system, the BD FACSPresto Near Patient CD4 Counter system (BD Biosciences), enables patients to monitor their HIV/AIDS, potentially reducing the probability of transmitting the ...

Treatment interruptions in patients with prolonged immunologic and virologic responses to highly active antiretroviral therapy (HAART) have been advocated in many circles, especially if the CD4+ count ...

Living with HIV means becoming fluent in a language of numbers that might seem confusing at first but actually hold the key to your health and future. Two numbers in particular – your viral load and ...

Implementation of electronic patient-reported outcomes for symptom monitoring in a large multi-site community oncology practice. A multicenter analysis of the outcome of cancer patients with ...

A CD4+ count below 200 cells/μL, advanced age at antiretroviral therapy initiation, and protease inhibitor use were associated with low-level viremia and increased risk for virologic failure among ...

HIV positive patients who take combination antiretroviral therapy (cART) to combat HIV infection could see the numbers of CD4 cells in their immune system rise to concentrations found in HIV negative ...